Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside

doi:10.4251/wjgo.v13.i4.197

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5770)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

398

WORD

209

HTML

3640

Figures (1-2)

248

Tables (1-2)

241

Sum=4736

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

392

Download

642

Sum=1034

Apr 15, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Apr 15, 2021; 13(4): 197-215
Published online Apr 15, 2021. doi: 10.4251/wjgo.v13.i4.197

Table 1 Non-invasive biomarkers for early diagnosis of hepatocellular carcinoma

Type of biomarker	Examples
Proteins	AFP; DCP; GALAD score; HES algorithm; ASAP model
Metabolites	A panel based on phenylalanyl-tryptophan and glycocholate
Circulating cell-free DNAs	Somatic mutations; DNA methylation; 5-hydroxymethylcytosine
Circulating non-coding RNAs	Micro-RNAs (mirR-125b, miR-122, and miR-21); Circular RNAs; Long non-coding RNAs; Exosomal non-coding RNAs

AFP: Alpha-fetoprotein; DCP: Des-gamma-carboxy prothrombin; HCC: Hepatocellular carcinoma; RNA: Ribonucleic acid.

Citation: Guan MC, Wang MD, Liu SY, Ouyang W, Liang L, Pawlik TM, Xu QR, Huang DS, Shen F, Zhu H, Yang T. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside. World J Gastrointest Oncol 2021; 13(4): 197-215
URL: https://www.wjgnet.com/1948-5204/full/v13/i4/197.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i4.197